Related Experiment Video
Updated: Jan 20, 2026
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
DANCR sponges miR-135a to regulate paclitaxel sensitivity in prostate cancer
1Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong. 18560083909@163.com.
Objective:
Paclitaxel is one of the most common drugs for cancer treatment. LncRNA DANCR is a regulator of up-regulation in tumors. Our experiment aims to clarify the role of DANCR in paclitaxel sensitivity of prostate cancer.
Patients And Methods:
We found that the expression of DANCR in prostate cancer tissues and cells was significantly higher than that in normal groups. DANCR knockdown could reduce cell proliferation and induce cell apoptosis in cells. Moreover, DANCR silence enhanced the effect of paclitaxel on cell proliferation and apoptosis in prostate cancer cells.
Results:
DANCR targeted and negatively regulated the expression of miR-135a. miR-135a overexpression inhibited cell proliferation and promoted cell apoptosis and paclitaxel sensitivity in prostate cancer cells. miR-135a inhibition reversed the promoting effect of DANCR silence on paclitaxel sensitivity in prostate cancer cells.
Conclusions:
Downregulation of DANCR increased paclitaxel sensitivity in prostate cancer cells by negatively regulating the expression of miR-135a.
Related Concept Videos
07:16Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
05:07Intra-prostatic Injection of Cancer Cells: A Technique to Deliver Cancer Cells for Establishing Orthotopic Prostate Cancer Mouse Model
11:29miRNA Expression Analyses in Prostate Cancer Clinical Tissues
06:48An Orthotopic Murine Model of Human Prostate Cancer Metastasis
11:07Focal Laser Ablation of Prostate Cancer: An Office Procedure
08:54Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer